Prostatis Group’s Health Care Select Sector SPDR Fund XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
1,530
-19
| -1% | -$2.56K | 0.06% | 153 |
|
|
2025
Q1 | $226K | Sell |
1,549
-319
| -17% | -$46.6K | 0.07% | 139 |
|
|
2024
Q4 | $257K | Sell |
1,868
-4
| -0.2% | -$550 | 0.07% | 135 |
|
|
2024
Q3 | $288K | Buy |
1,872
+37
| +2% | +$5.7K | 0.09% | 113 |
|
|
2024
Q2 | $267K | Sell |
1,835
-523
| -22% | -$76.2K | 0.09% | 125 |
|
|
2024
Q1 | $348K | Buy |
2,358
+216
| +10% | +$31.9K | 0.13% | 109 |
|
|
2023
Q4 | $285K | Sell |
2,142
-1,155
| -35% | -$153K | 0.12% | 108 |
|
|
2023
Q3 | $424K | Sell |
3,297
-382,628
| -99% | -$49.3M | 0.21% | 72 |
|
|
2023
Q2 | $414K | Buy |
385,925
+382,607
| +11,531% | +$410K | 0.19% | 78 |
|
|
2023
Q1 | $431K | Sell |
3,318
-17,272
| -84% | -$2.24M | 0.23% | 72 |
|
|
2022
Q4 | $2.8M | Buy |
20,590
+18,668
| +971% | +$2.54M | 1.71% | 14 |
|
|
2022
Q3 | $233K | Buy |
1,922
+64
| +3% | +$7.75K | 0.27% | 54 |
|
|
2022
Q2 | $238K | Buy |
1,858
+280
| +18% | +$35.9K | 0.37% | 38 |
|
|
2022
Q1 | $216K | Buy |
+1,578
| New | +$216K | 0.17% | 76 |
|
|
2021
Q3 | – | Sell |
-12,852
| Closed | -$1.62M | – | 109 |
|
|
2021
Q2 | $1.62M | Buy |
12,852
+6,709
| +109% | +$845K | 1.11% | 26 |
|
|
2021
Q1 | $717K | Buy |
+6,143
| New | +$717K | 0.56% | 43 |
|
|
2020
Q2 | – | Sell |
-21,546
| Closed | -$1.91M | – | 80 |
|
|
2020
Q1 | $1.91M | Buy |
+21,546
| New | +$1.91M | 2.71% | 12 |
|